Machine learning for mathematical models of HCV kinetics during antiviral therapy
From MaRDI portal
Publication:2118485
Recommendations
- Towards prediction of HCV therapy efficiency
- Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents
- A Mathematical Model for the Dynamics of Hepatitis C
- Mathematical modeling of hepatitis B virus infection for antiviral therapy using LHAM
- Dynamics of hepatitis C virus infection: mathematical modeling and parameter estimation
- Viral kinetic modeling of chronic hepatitis C and B infection
- Mathematical Modelling of HIV-HCV Co-infection Dynamics in Presence of HIV Therapy
- Innovative approximate analytical solution for standard model of viral dynamics: hepatitis C with direct-acting agents as an implemented case
- Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin
- Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy
Cites work
- A method for the solution of certain non-linear problems in least squares
- A parameter estimation method for multiscale models of hepatitis C virus dynamics
- An Algorithm for Least-Squares Estimation of Nonlinear Parameters
- HIV-1 infection and low steady state viral loads
- scientific article; zbMATH DE number 1392848 (Why is no real title available?)
- Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy
- Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity
- Nonlinear diffusion filtering on extended neighborhood
- Numerical schemes for solving and optimizing multiscale models with age of hepatitis C virus dynamics
- On identifiability of nonlinear ODE models and applications in viral dynamics
- Random forests
Cited in
(5)- Using machine learning algorithms to predict hepatitis B surface antigen seroclearance
- Combining mathematical modeling and deep learning to make rapid and explainable predictions of the patient-specific response to anticoagulant therapy under venous flow
- Towards prediction of HCV therapy efficiency
- Penalized trinomial logit models distinguish clinical stages in patients with hepatitis
- Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis
This page was built for publication: Machine learning for mathematical models of HCV kinetics during antiviral therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2118485)